Albireo Pharma, Inc. is a company in the U.S. stock market and it is a holding in 29 U.S.-traded ETFs. ALBO has around 1.6M shares in the U.S. ETF market. The largest ETF holder of ALBO is the SPDR S&P Biotech ETF (XBI), with approximately 636.61K shares. Investors may also find of interest that the ETF with the largest allocation to ALBO stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 0.36%. On average, U.S. ETFs allocate 0.04% of ALBO to their portfolios.
Additionally, ALBO is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ALBO as a holding is the Dimensional U.S. Core Equity Market ETF (DFAU), with a return of 22.52%.